Exane Derivatives’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
Other funds holding CTVA
Exane Derivatives's CTVA Position: Q2 2022 in Review
Exane Derivatives reduced its Corteva (CTVA) stake by 100% in Q2 2022, selling an estimated $158K and leaving 12 shares worth $650. The position accounts for ﹤0.01% of the portfolio, ranked #548.
Exane Derivatives first reported a position in CTVA in Q2 2021 and has held it in 5 quarters since. The position peaked at $306K in Q2 2021. 1,191 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.
- Exane Derivatives held 12 shares of Corteva worth $650 as of Q2 2022.
- Exane Derivatives sold 2,725 Corteva shares in Q2 2022, an estimated $158K.
- Corteva made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #548 holding.
- Exane Derivatives first reported a position in Corteva in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's Corteva position peaked at $306K in Q2 2021.
- 1,191 funds tracked by Wall St. Rank held Corteva as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.